知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

6 records (took 0.017 seconds)

    APICAL PUNCTURE ACCESS AND CLOSURE SYSTEM
    2.
    发明申请
    APICAL PUNCTURE ACCESS AND CLOSURE SYSTEM 有权
    自动通道接近和闭合系统

    公开(公告)号：US20150272559A1

    公开(公告)日：2015-10-01

    申请号：US14735034

    申请日：2015-06-09

    Applicant: Edwards Lifesciences Corporation

    Inventor： Stanton J. Rowe ,  Ming H. Wu ,  Ralph Schneider ,  Philip P. Corso, JR.

    IPC: A61B17/00 ,  A61B17/02

    CPC classification number: A61B17/0057 ,  A61B17/00234 ,  A61B17/02 ,  A61B17/0293 ,  A61B17/3478 ,  A61B2017/00243 ,  A61B2017/00247 ,  A61B2017/00579 ,  A61B2017/00592 ,  A61B2017/00597 ,  A61B2017/00601 ,  A61B2017/00606 ,  A61B2017/00623 ,  A61B2017/00628 ,  A61B2017/00637 ,  A61B2017/00668 ,  A61B2017/00867 ,  A61B2017/00991 ,  A61B2017/0237 ,  A61B2017/3425

    Abstract: A device, system, and method for providing access to, and sealing of, a body organ includes an implant device. An implant device has a main body having an internal access lumen, with a plurality of prongs extending from a distal end of the main body. The main body can include two lumens, one slidable within the other, to form a single continuous lumen with an adjustable length. The main body has an expanded configuration with an expanded diameter, and an unexpanded configuration with an unexpanded diameter. The prongs have a generally straight configuration where they extend distally of the distal end of the main body, and a bent configuration where the prongs bend around so that their tips extend proximally of the distal end of the main body. The device may include a hemostatic barrier to prevent fluid leakage therethrough when the main body is in the unexpanded configuration.

    Abstract translation: 用于提供身体器官的接近和密封的装置，系统和方法包括植入装置。 植入装置具有主体，其具有内部进入腔，多个尖端从主体的远端延伸。 主体可以包括两个腔，一个可在另一个内滑动，以形成具有可调节长度的单个连续内腔。 主体具有扩展的直径扩张构型和未膨胀直径的未膨胀构造。 尖头具有大致直的构造，其中它们远离主体的远端延伸，并且弯曲构造，其中尖头弯曲，使得其尖端在主体的远端的近端延伸。 当主体处于未膨胀构型时，该装置可以包括止血屏障以防止流体从其中泄漏。

    RETAINING MECHANISMS FOR PROSTHETIC VALVES
    4.
    发明申请
    RETAINING MECHANISMS FOR PROSTHETIC VALVES 有权

    公开(公告)号：US20220071766A1

    公开(公告)日：2022-03-10

    申请号：US17455207

    申请日：2021-11-16

    Applicant: Edwards Lifesciences Corporation

    Inventor： Christopher J. Olson ,  Glen T. Rabito ,  Dustin P. Armer ,  Minh T. Ma ,  Devin H. Marr ,  Cheng-Tung Huang ,  Hiroshi Okabe ,  Kevin M. Stewart ,  Alison S. Curtis ,  Philip P. Corso, JR.

    IPC: A61F2/24

    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve assembly. In embodiments, a prosthetic heart valve assembly, including a self-expandable support structure and a self-expanding heart valve, are advanced through the aortic arch of a patient using a delivery system. The support structure, which includes a plurality leaflet retaining arms, is at least partially expanded and positioned on or adjacent to the outflow side of the aortic valve. The prosthetic heart valve is positioned in the aortic valve. The prosthetic heart valve is expanded while it is within an interior of the support structure and while the support structure is positioned on or adjacent to the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the arms of the support structure and the expanded prosthetic heart valve.

    TREATMENTS FOR MITRAL VALVE INSUFFICIENCY
    5.
    发明申请
    TREATMENTS FOR MITRAL VALVE INSUFFICIENCY 审中-公开
    麻醉药物治疗

    公开(公告)号：US20170056176A1

    公开(公告)日：2017-03-02

    申请号：US15244716

    申请日：2016-08-23

    Applicant: Edwards Lifesciences Corporation

    Inventor： Stanton J. Rowe ,  Jinny Lee ,  Philip P. Corso, JR. ,  Mark Chau ,  David L. Hauser

    IPC: A61F2/24

    CPC classification number: A61F2/2487 ,  A61B17/0487 ,  A61B2017/00358 ,  A61B2017/0417 ,  A61B2017/0464 ,  A61F2/2412 ,  A61F2/2418 ,  A61F2/2427 ,  A61F2/2442 ,  A61F2/2454 ,  A61F2/246 ,  A61F2/2463 ,  A61F2/2466 ,  A61F2250/006

    Abstract: The present disclosure concerns embodiments of an implantable device that are used to treat an insufficient heart valve that has been previously treated by implantation of a fixation device or an Alfieri stitch that is secured to opposing portions of the native leaflets. In one representative embodiment, an implantable device for remodeling a native mitral valve having two native leaflets and a fixation device or an Alfieri stitch secured to respective free edges of the leaflets is configured to be coupled to the fixation device or Alfieri stitch and apply a remodeling force to the native mitral valve that draws the native leaflets toward each other to promote coaptation of the leaflets.

    Abstract translation: 本公开涉及可植入装置的实施例，其用于治疗先前已经通过植入固定在天然传单的相对部分的固定装置或Alfieri针迹来治疗的心脏瓣膜不足。 在一个代表性的实施例中，用于重塑具有两个天然传单的固有二尖瓣的可植入装置和固定到小叶各自的自由边缘上的固定装置或固定装置被配置成联接到固定装置或Alfieri针迹并施加重塑 对原生二尖瓣施加力量，将本地传单彼此拉开，以促进传单的接合。

    RETAINING MECHANISMS FOR PROSTHETIC VALVES
    6.
    发明申请
    RETAINING MECHANISMS FOR PROSTHETIC VALVES 审中-公开
    保留机构的前置阀

    公开(公告)号：US20160228240A1

    公开(公告)日：2016-08-11

    申请号：US15130402

    申请日：2016-04-15

    Applicant: Edwards Lifesciences Corporation

    Inventor： Christopher J. Olson ,  Glen Thomas Rabito ,  Dustin P. Armer ,  Minh T. Ma ,  Devin H. Marr ,  Cheng-Tung Huang ,  Hiroshi Okabe ,  Kevin M. Stewart ,  Alison S. Curtis ,  Philip P. Corso, JR.

    IPC: A61F2/24

    CPC classification number: A61F2/243 ,  A61F2/2418 ,  A61F2/2427 ,  A61F2/2433 ,  A61F2/2436 ,  A61F2/2439 ,  A61F2220/0016 ,  A61F2220/005 ,  A61F2220/0075 ,  A61F2230/0054 ,  A61F2230/0076 ,  A61F2250/006

    Abstract: Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve to a deficient valve. In one embodiment, for instance, a support structure and an expandable prosthetic valve are advanced through the aortic arch of a patient using a delivery system. The support structure is delivered to a position on or adjacent to the surface of the outflow side of the aortic valve (the support structure defining a support-structure interior). The expandable prosthetic valve is delivered into the aortic valve and into the support-structure interior. The expandable prosthetic heart valve is expanded while the expandable prosthetic heart valve is in the support-structure interior and while the support structure is at the position on or adjacent to the surface of the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the support structure and the expanded prosthetic heart valve.

    Abstract translation: 这里公开了用于将假性心脏瓣膜递送到缺陷阀的方法，装置和系统的代表性实施例。 在一个实施例中，例如，支撑结构和可扩张的假体瓣膜通过使用递送系统的患者的主动脉弓前进。 支撑结构被传送到主动脉瓣（支撑结构限定支撑结构内部）的流出侧的表面上或邻近的位置。 可膨胀假体瓣膜被输送到主动脉瓣并进入支撑结构内部。 可扩张假体心脏瓣膜膨胀，而可扩张假体心脏瓣膜处于支撑结构内部，而支撑结构处于主动脉瓣的流出侧表面上或邻近主动脉瓣的流出侧的位置，从而导致一个或多个本机 主动脉瓣的小叶被摩擦地固定在支撑结构和扩张的假体心脏瓣膜之间。

Patent Agency Ranking